510(k) Report

510(k) · Cleared

Cleared

NeuroStar TMS Therapy System

K160703510(k) TraditionalCleared Jun 10, 201688-day reviewClass II21 CFR 882.5805

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neuronetics, Inc. · OBP Transcranial Magnetic Stimulator

Cleared on Jun 10, 2016 as substantially equivalent to K133408 (Neuronetics, 2014) after an 88-day review. Its family tree reaches back 4 generations to 2008. 55 later devices descend from it.

Decided
Jun 10, 2016
Review
88 days
Class
Class II
Product code
OBP
Recalls
None
Predicates
1

Its longest line of descent runs back 4 generations to DEN070003 (2008). 55 later devices descend from it, 8 citing it directly.

Descendants, by year cleared 2023: 10 descendants cleared2018: 3 descendants cleared2016: 1 descendant cleared2022: 5 descendants cleared2017: 2 descendants cleared2020: 2 descendants cleared2025: 12 descendants cleared2019: 3 descendants cleared2026: 9 descendants cleared2024: 5 descendants cleared2021: 3 descendants cleared×2: 2 generations cleared close together, DEN070003 (2008), K083538 (2008) K130233 · Neurostar TMS Therapy System · Neuronetics · 2013K133408 · Neurostar TMS Therapy System · Neuronetics · 201420052010201520202025
Descendants, by generation 1 generation forward: 8 descendants2 generations forward: 18 descendants3 generations forward: 21 descendants4 generations forward: 6 descendants5 generations forward: 2 descendants K133408 · Neurostar TMS Therapy System · Neuronetics · 2014K130233 · Neurostar TMS Therapy System · Neuronetics · 2013K083538 · Neurostar TMS Therapy System, Model 1.1 · Neuronetics · 2008 · recalledDEN070003 · Neurostar TMS System · Neuronetics · 20080+5
  1. Root · 4 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
  2. 3 generations backK083538 Neurostar TMS Therapy System, Model 1.1Neuronetics · 2008 · Recalled
  3. 2 generations backK130233 Neurostar TMS Therapy SystemNeuronetics · 2013
  4. 1 generation backK133408 Neurostar TMS Therapy SystemNeuronetics · 2014
  5. This deviceK160703 NeuroStar TMS Therapy SystemNeuronetics, Inc. · 2016
  6. Descendant · cites it directly · 48 of its ownK171481 MagVita TMS Therapy SystemTonica Elektronik A/S · 2017
  7. Descendant · 2 generations on · 39 of its ownK173620 Mag Vita TMS Therapy System w/Theta Burst StimulationTonica Elektronik A/S · 2018
  8. Descendant · cites it directly · 27 of its ownK161519 NeuroStar TMS Therapy SystemNeuronetics, Inc. · 2016
  9. Descendant · 2 generations on · 24 of its ownK201158 NeuroStar Advanced TherapyNeuronetics, Inc. · 2020
  10. Descendant · 2 generations on · 24 of its ownK193006 MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS…Tonica Elektronik A/S · 2020

Showing 5 of 55 descendants. See all descendants

Descendants cleared per year

2016: 12017: 22018: 32019: 32020: 22021: 32022: 52023: 102024: 52025: 122026: 9
2016high 12 (2025) · low 1 (2016)2026

Most influential descendants

Showing 5 of 55 · See all
  • K171481MagVita TMS Therapy SystemTonica Elektronik A/S · 2017 · cites it directly48descendants
  • K173620Mag Vita TMS Therapy System w/Theta Burst StimulationTonica Elektronik A/S · 2018 · 2 generations on39descendants
  • K161519NeuroStar TMS Therapy SystemNeuronetics, Inc. · 2016 · cites it directly27descendants
  • K201158NeuroStar Advanced TherapyNeuronetics, Inc. · 2020 · 2 generations on24descendants
  • K193006MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy systemTonica Elektronik A/S · 2020 · 2 generations on24descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4DEN070003Neurostar TMS SystemNeuronetics2008—
−3K083538Neurostar TMS Therapy System, Model 1.1Neuronetics20081
−2K130233Neurostar TMS Therapy SystemNeuronetics2013—
−1K133408Neurostar TMS Therapy SystemNeuronetics2014—
0 (this device)K160703NeuroStar TMS Therapy SystemNeuronetics, Inc.2016—
+1K171481MagVita TMS Therapy SystemTonica Elektronik A/S2017—
+2K173620Mag Vita TMS Therapy System w/Theta Burst StimulationTonica Elektronik A/S2018—
+1K161519NeuroStar TMS Therapy SystemNeuronetics, Inc.2016—
+2K201158NeuroStar Advanced TherapyNeuronetics, Inc.2020—
+2K193006MagVenture TMS Therapy – for treatment of OCD, MagVenture TMS Therapy systemTonica Elektronik A/S2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
201720
201830
201930
202020
202130
202250
2023100
202450
2025120
202690
FIG. 1 — Lineage of K160703, 2008–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OBP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OBP device

  1. #1 K251119 MagVenture TMS Therapy Systemscore 21.8 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133408Neurostar TMS Therapy System
Summary page 4
…c Stimulator for Treatment of Major Depressive Disorder [21 CFR 882.5805, Product Code OBP] Predicate Device: NeuroStar TMS Therapy® System [K133408] Device Description: The NeuroStar TMS Therapy System is a computerized, electromechanical medical device that produces and de…
Neuronetics2014—

Also cleared against K133408: 8 other devices →

What descends from it? (55)

See all 55

8 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K171481MagVita TMS Therapy SystemTonica Elektronik A/S201748
K161519NeuroStar TMS Therapy SystemNeuronetics, Inc.201627
K212289NeuroStar Advanced Therapy for adjunctive treatment of OCD, NeuroStar Advanced Therapy…Neuronetics, Inc.202219
K220127NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar, NeuroStar…Neuronetics, Inc.202216
K230029NeuroStar Advanced Therapy System (Version 3.7)Neuronetics202313
K180907HORIZON TMS Therapy SystemMagstim Company, Ltd.201812
K233621NeuroStar Advanced Therapy System (Version 3.8)Neuronetics20231
K222230NeuroStar, NeuroStar TMS Therapy System, NeuroStar Advanced Therapy System, NeuroStar…Neuronetics, Inc.20220

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 2 companies; a new generation was cleared every 2.2 years on median.
  • 1 of the 4 ancestors has a recall of any class.
  • Of its descendants, K171481 (Tonica Elektronik A/S, 2017) has gone furthest, with 48 descendants of its own.
  • 8 other devices also cite its predicate K133408.

How does its category compare?

All OBP devices

OBP Transcranial Magnetic Stimulator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.

FDA decisions per year · OBP

12in 2025

2008: 22013: 22014: 12015: 22016: 32017: 82018: 42019: 32020: 12021: 52022: 62023: 72024: 52025: 122026 (partial year): 8
2007high 12 (2025) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OBP

125in 2025

2016: 101 days median2017: 73 days median2018: 144 days median2019: 156 days median2021: 132 days median2022: 168 days median2023: 119 days median2024: 266 days median2025: 125 days median2026 (partial year): 176 days median
2007high 266 (2024) · low 73 (2017)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OBP

1in 2018

2009: 12018: 12026 (partial year): 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OBP

81in 2025

2009: 32011: 52012: 32013: 12015: 32016: 62017: 32018: 62019: 122020: 122021: 152022: 592023: 432024: 502025: 81
2007high 81 (2025) · low 0 (2007)2025

MAUDE reports naming product code OBP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20082—00
20090—13
20100—00
20110—05
20120—03
20132—01
20141—00
20152—03
2016310106
201787303
2018414416
20193156012
20201—012
20215132015
20226168059
20237119043
20245266050
202512125081
202681761—

What is it indicated for?

The NeuroStar TMS Therapy System is indicated for the treatment of Major Depressive Disorder in adult patients who

have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K160703: NeuroStar TMS Therapy System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K160703

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026